Status:

COMPLETED

Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study

Lead Sponsor:

AtriCure, Inc.

Conditions:

Persistent Atrial Fibrillation

Longstanding Persistent Atrial Fibrillation

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this clinical investigation is to evaluate how safe a less invasive cardiac surgery is using the AtriCure Bipolar System combined with a catheter ablation procedure in treating AF, and ...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Patients with symptomatic (e.g. palpitations, shortness of breath, fatigue) persistent or longstanding persistent AF Persistent
  • Patient is willing and able to provide written informed consent.
  • Patient has a life expectancy of at least 2 years.
  • Patient is willing and able to attend the scheduled follow-up visits.

Exclusion

  • Prior Cardiothoracic Surgery.
  • Patient has NYHA Class IV heart failure.
  • Evidence of underlying structural heart disease requiring surgical treatment.
  • Ejection fraction \< 30%
  • Measured left atrial diameter \> 6.0 cm
  • Renal Failure
  • Stroke within previous 6 months.
  • Known carotid artery stenosis greater than 80%.
  • Evidence of significant active infection or endocarditis.
  • Pregnant woman or women desiring to become pregnant in the next 24 months.
  • Presence of thrombus in the left atrium determined by echocardiography.
  • History of blood dyscrasia.
  • Contraindication to anticoagulation, based on Investigator's opinion.
  • Mural thrombus or tumor.
  • Moderate to Severe COPD

Key Trial Info

Start Date :

December 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2013

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT01246466

Start Date

December 1 2010

End Date

November 1 2013

Last Update

April 1 2021

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Stanford University Medical Center

Stanford, California, United States, 94305

2

Vanderbilt Heart Institute

Nashville, Tennessee, United States, 37232

3

Baylor Health

Plano, Texas, United States, 75093

4

UVA

Charlottesville, Virginia, United States, 22908